Q2 2026 Perrigo Company PLC Earnings Call Transcript
Key Points
- Perrigo Co PLC (PRGO) gained market share across its portfolio, with US store brand OTC volumes growing 1.5% and European key brands growing 3.3%, each taking 50 basis points of share despite category declines.
- The company's operational enhancement program is on track to deliver $80 million to $100 million in savings by 2027, with accelerated implementation contributing to better-than-expected Q2 earnings.
- Infant formula showed strong improvement, growing 23% year-over-year, with operating income up approximately $16 million due to capacity rationalization, efficiency gains, and a successful FDA audit with no observations.
- Perrigo Co PLC (PRGO) strengthened its balance sheet by applying the majority of the $359 million Derma Cosmetics divestiture proceeds to debt reduction, significantly lowering its revolving credit facility balance.
- The innovation pipeline value has more than tripled since 2024, with over 55% of projects leveraging shared platforms, enabling more efficient and scalable investments across brands and store brands.
- Service levels have improved significantly, up 1,600 basis points to 91% in the US and 1,000 basis points to 95% internationally since 2023, strengthening customer relationships and supporting share gains.
- Core net sales declined 3.1% year-over-year, impacted by continued category softness, a slow start to summer seasonal categories, and retailer destocking, particularly in Europe.
- The company experienced a 1.8% negative impact from retailer inventory reductions, most notably in Europe, which pressured reported results despite improving category trends.
- Core adjusted gross margin declined 150 basis points to 37%, driven by lower sales volumes, planned underabsorption from prior year sales volumes, and unfavorable mix.
- Self-care operating income declined 16.2% and specialty care operating income decreased 28%, pressured by lower volumes, a slower start to seasonal categories, and higher advertising investments.
- Perrigo Co PLC (PRGO) maintained its full-year outlook despite Q2 earnings beating expectations, citing one-time benefits like a $6 million CEO transition cost and $10 million tariff recovery that are not expected to recur.
- The company faces ongoing uncertainty from consumer weakness and macroeconomic pressures, particularly in Europe, with planned underabsorption expected to result in an unfavorable all-in EPS impact of approximately $0.60 in 2026.
Good morning, ladies and gentlemen, and welcome to the Perrigo Q2 2026 Financial Results Conference Call. (Operator Instructions) I would now like to turn the conference over to Eric Jacobson, the Global Investor Relations. Please go ahead, sir.
Good morning and good afternoon, everyone. Welcome to Perrigo's second quarter 2026 earnings conference call.
A copy of the release we issued today and the accompanying presentation are available within the investors section of the Perrigo.com website.
Joining today's call are Perigo's Interim President and CEO, Albert Manzoni, and CFO, Eduardo Bizarra.
During this presentation, participants will make certain forward-looking statements.
Please refer to the slides for information regarding these statements, which are subject to important risks and uncertainties.
We will reference adjusted financial measures that are non-GAAP in nature.
See the appendix to the earnings presentation for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
